Melanoma, a type of skin cancer, is often curable when detected and treated in its early stages. However, the disease can rapidly spread to other organs in the body and become deadly. According to the American Cancer Society, ...
Feb 17, 2022
0
20
Neural stem cells (NSCs) engineered by Northwestern Medicine investigators used in combination with the HER2 inhibitor drug tucatinib improved survival in mice with HER2-positive breast cancer brain metastases, according ...
Feb 2, 2022
0
97
'Prehab' exercise may boost the impact of chemotherapy given to patients with cancer of the food pipe (oesophagus) to shrink their tumour (s) before surgery, reveals the first study of its kind, published online in the British ...
Feb 1, 2022
0
8
Nearly 50 percent of blood cancer patients do not have detectable levels of antibodies able to neutralize the omicron SARS-CoV-2 variant after a third vaccine dose, according to new laboratory data from the Francis Crick ...
Jan 26, 2022
0
6
Removing one type of T cell from donor blood used for stem cell grafts could greatly reduce a serious complication called graft-versus-host disease in patients with leukemia, according to a new study.
Jan 10, 2022
0
11
Nearly 100 percent of cancer patients with solid tumors have antibodies effective against the delta variant after a third dose of COVID-19 vaccine, according to new results published as a correspondence in Cancer Cell this ...
Dec 23, 2021
0
59
WEHI researchers have developed enhanced imaging technology that can model how breast cancer cells invade and spread into bone and remodify themselves to fuel tumor growth.
Dec 17, 2021
0
94
An immunotherapy harnessing the immune system's "natural killer" cells has proven effective in treating acute myeloid leukemia (AML) in some adults whose cancers return. Now, researchers at Washington University School of ...
Dec 14, 2021
0
36
A drug combination can safely prevent transplanted stem cells (graft) from attacking the recipient's (host) body, allowing them to develop into healthy new blood and immune cells, a new study shows.
Dec 13, 2021
0
49
An international team has developed statistical models to predict the risk of early death in patients being treated with non-intensive therapies for acute myeloid leukemia (AML). Results of analyses using the models will ...
Dec 12, 2021
0
1
